RecruitingNCT04797299

Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ (DCIS)

Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ Defined by a Molecular Expression Assay Combined With Clinico-Pathological Features


Sponsor

Ontario Clinical Oncology Group (OCOG)

Enrollment

526 participants

Start Date

Nov 23, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

To evaluate whether the combination of clinicopathological factors and the use of the Oncotype DX DCIS score can avoid radiation in women with low risk DCIS who have had breast conserving surgery (BCS)


Eligibility

Sex: FEMALEMin Age: 46 Years

Inclusion Criteria5

  • Female patient \> 45 years of age with DCIS without microinvasion.
  • Tumour size ≤ 2.5cm.
  • Treated by BCS with clear resection margins ≥ 2 mm or no residual disease on re-excision.\*
  • \* Patients with anterior margins and posterior margins ≥1 mm are eligible. Or if the dissection was confirmed to be taken to skin and down to fascia with no DCIS present at inked margins.
  • Oncotype DX DCIS score with a predicted 10-year risk of LR ≤10%.

Exclusion Criteria7

  • Multifocal DCIS.
  • History of any invasive breast cancer or non-invasive breast cancer in the ipsilateral breast.
  • Synchronous or previous invasive or non-invasive breast cancer.
  • Prior history of invasive cancer within the last 5 years, excluding non-melanoma skin cancers.
  • ECOG performance status ≥3.
  • Life expectancy \<10 years.
  • Geographic inaccessibility for follow-up.

Locations(24)

Arthur J.E. Child Comprehensive Cancer Centre

Calgary, Alberta, Canada

Cross Cancer Institute

Edmonton, Alberta, Canada

BC Cancer - Abbotsford Centre

Abbotsford, British Columbia, Canada

BC Cancer - Centre for the North (Prince George)

Prince George, British Columbia, Canada

BC Cancer - Fraser Valley Centre

Surrey, British Columbia, Canada

BC Cancer - Vancouver Centre

Vancouver, British Columbia, Canada

BC Cancer - Victoria

Victoria, British Columbia, Canada

QE II HSC - Nova Scotia Cancer Centre

Halifax, Nova Scotia, Canada

Cape Breton Cancer Centre

Sydney, Nova Scotia, Canada

Royal Victoria Regional Health Centre

Barrie, Ontario, Canada

Juravinski Cancer Centre

Hamilton, Ontario, Canada

London Regional Cancer Program

London, Ontario, Canada

Regional Cancer Care, Thunder Bay Regional Health Sciences Centre

Thunder Bay, Ontario, Canada

Sunnybrook Health Science Centre -Odette Cancer Centre

Toronto, Ontario, Canada

University Health Network - Princess Margaret Cancer Centre

Toronto, Ontario, Canada

Windsor Regional Cancer Centre

Windsor, Ontario, Canada

Hôpital Charles Le Moyne (CISSS de la Montérégie-Centre)

Greenfield Park, Quebec, Canada

CHUM - Centre Hospitalier de L'Université de Montréal

Montreal, Quebec, Canada

Jewish General Hospital

Montreal, Quebec, Canada

McGill University Health Centre

Montreal, Quebec, Canada

Centre intégré de cancérologie du CHU de Québec - Université Laval

Québec, Quebec, Canada

Centre Intégré Universitaire de Santé et de Services Sociaux de la Mauricie- Centre-du-Québec (CIUSSS MCQ) - Trois-Rivières

Trois-Rivières, Quebec, Canada

Allan Blair Cancer Centre

Regina, Saskatchewan, Canada

Saskatoon Cancer Centre

Saskatoon, Saskatchewan, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04797299


Related Trials